Recognizing detachment-mode seafloor spreading in the deep geological past.

Large-offset oceanic detachment faults are a characteristic of slow- and ultraslow-spreading ridges, leading to the formation of oceanic core complexes (OCCs) that expose upper mantle and lower crustal rocks on the seafloor. The lithospheric extension accommodated by these structures is now recognized as a fundamentally distinct “detachment-mode” of seafloor spreading compared to classical magmatic accretion. Here we demonstrate a paleomagnetic methodology that allows unequivocal recognition of detachment-mode seafloor spreading in ancient ophiolites and apply this to a potential Jurassic detachment fault system in the Mirdita ophiolite (Albania). We show that footwall and hanging wall blocks either side of an inferred detachment have significantly different magnetizations that can only be explained by relative rotation during seafloor spreading. The style of rotation is shown to be identical to rolling hinge footwall rotation documented recently in OCCs in the Atlantic, confirming that detachment-mode spreading operated at least as far back as the Jurassic

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

Background and purpose: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. Methods: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). Results: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. Conclusions: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality.

BACKGROUND AND PURPOSE: Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year. METHODS: We conducted a cross-sectional retrospective study of 171 stroke centers from 49 countries. We recorded COVID-19 admission volumes, CVT hospitalization, and CVT in-hospital mortality from January 1, 2019, to May 31, 2021. CVT diagnoses were identified by International Classification of Disease-10 (ICD-10) codes or stroke databases. We additionally sought to compare the same metrics in the first 5 months of 2021 compared to the corresponding months in 2019 and 2020 (ClinicalTrials.gov Identifier: NCT04934020). RESULTS: There were 2,313 CVT admissions across the 1-year pre-pandemic (2019) and pandemic year (2020); no differences in CVT volume or CVT mortality were observed. During the first 5 months of 2021, there was an increase in CVT volumes compared to 2019 (27.5%; 95% confidence interval [CI], 24.2 to 32.0; P<0.0001) and 2020 (41.4%; 95% CI, 37.0 to 46.0; P<0.0001). A COVID-19 diagnosis was present in 7.6% (132/1,738) of CVT hospitalizations. CVT was present in 0.04% (103/292,080) of COVID-19 hospitalizations. During the first pandemic year, CVT mortality was higher in patients who were COVID positive compared to COVID negative patients (8/53 [15.0%] vs. 41/910 [4.5%], P=0.004). There was an increase in CVT mortality during the first 5 months of pandemic years 2020 and 2021 compared to the first 5 months of the pre-pandemic year 2019 (2019 vs. 2020: 2.26% vs. 4.74%, P=0.05; 2019 vs. 2021: 2.26% vs. 4.99%, P=0.03). In the first 5 months of 2021, there were 26 cases of vaccine-induced immune thrombotic thrombocytopenia (VITT), resulting in six deaths. CONCLUSIONS: During the 1st year of the COVID-19 pandemic, CVT hospitalization volume and CVT in-hospital mortality did not change compared to the prior year. COVID-19 diagnosis was associated with higher CVT in-hospital mortality. During the first 5 months of 2021, there was an increase in CVT hospitalization volume and increase in CVT-related mortality, partially attributable to VITT

Hydrothermal Prospection in the Red Sea Rift: Geochemical Messages from Basalts

Hydrothermal circulation at mid-ocean ridges and assimilation of hydrothermally altered crust or hydrothermal fluids by rising magma can be traced by measuring chlorine (Cl) excess in erupted lavas. The Red Sea Rift provides a unique opportunity to study assimilation of hydrothermally altered crust at an ultra-slow spreading ridge (maximum 1.6 cm yr−1 full spreading rate) by Cl, due to its saline seawater (40–42‰, cf. 35‰ in open ocean water), the presence of (hot) brine pools (up to 270‰ salinity and 68 °C) and the thick evaporite sequences that flank the young rift. Absolute chlorine concentrations (up to 1300 ppm) and Cl concentrations relative to minor or trace elements of similar mantle incompatibility (e.g., K, Nb) are much higher in Red Sea basalts than in basalts from average slow spreading ridges. Mantle Cl/Nb concentrations can be used to calculate the Cl-excess, above the magmatic Cl, that is present in the samples. Homogeneous within-sample Cl concentrations, high Cl/H2O, the decoupling of Cl-excess from other trace elements and its independence of the presence of highly saline seafloor brines at the site of eruption indicate that Cl is not enriched at the seafloor. Instead we find basaltic Cl-excess to be spatially closely correlated with evidence of hydrothermal activity, suggesting that deeper assimilation of hydrothermal Cl is the dominant Cl-enrichment process. A proximity of samples to both evaporite outcrops and bathymetric signs of volcanism on the seafloor enhance Cl-excess in basalts. The basaltic Cl-excess can be used as a tracer together with new bathymetric maps as well as indications of hydrothermal venting (hot brine pools, metalliferous Hydrothermal circulation at mid-ocean ridges and assimilation of hydrothermally altered crust or hydrothermal fluids by rising magma can be traced by measuring chlorine (Cl) excess in erupted lavas. The Red Sea Rift provides a unique opportunity to study assimilation of hydrothermally altered crust at an ultra-slow spreading ridge (maximum 1.6 cm yr−1 full spreading rate) by Cl, due to its saline seawater (40–42‰, cf. 35‰ in open ocean water), the presence of (hot) brine pools (up to 270‰ salinity and 68 °C) and the thick evaporite sequences that flank the young rift. Absolute chlorine concentrations (up to 1300 ppm) and Cl concentrations relative to minor or trace elements of similar mantle incompatibility (e.g., K, Nb) are much higher in Red Sea basalts than in basalts from average slow spreading ridges. Mantle Cl/Nb concentrations can be used to calculate the Cl-excess, above the magmatic Cl, that is present in the samples. Homogeneous within-sample Cl concentrations, high Cl/H2O, the decoupling of Cl-excess from other trace elements and its independence of the presence of highly saline seafloor brines at the site of eruption indicate that Cl is not enriched at the seafloor. Instead we find basaltic Cl-excess to be spatially closely correlated with evidence of hydrothermal activity, suggesting that deeper assimilation of hydrothermal Cl is the dominant Cl-enrichment process. A proximity of samples to both evaporite outcrops and bathymetric signs of volcanism on the seafloor enhance Cl-excess in basalts. The basaltic Cl-excess can be used as a tracer together with new bathymetric maps as well as indications of hydrothermal venting (hot brine pools, metalliferous sediments) to predict where hydrothermal venting or now inactive hydrothermal vent fields can be expected. Sites of particular interest for future hydrothermal research are the Mabahiss Deep, the Thetis-HadarbaHatiba Deeps and Shagara-Aswad-Erba Deeps (especially their large axial domes), and Poseidon Deep. Older hydrothermal vent fields may be present at the Nereus and Suakin Deeps. These sites significantly increase the potential of hydrothermal vent field prospection in the Red Sea